Barbados is moving forward with landmark new legislation aimed at closing long-standing gaps in medical product oversight, responding to growing public alarm over the circulation of banned, untested goods and misleading cure-all advertising that targets vulnerable consumers.
The Barbados Medical Products Bill, which was introduced for debate in the country’s House of Assembly this Tuesday, will bring sweeping new checks to all medical and health-related goods imported into the island nation, Economic Affairs and Planning Minister Marsha Caddle told lawmakers. Caddle outlined a long-running pattern of unsafe trade that has put Barbadians at risk: items that have been pulled from shelves and banned in major global markets for health and safety reasons often remain widely available in Barbados for years after their prohibition elsewhere.
In one particularly egregious example, Caddle noted that some products explicitly marked “for export only” by their manufacturing countries end up on Barbadian retail shelves. This practice, she explained, reveals a cynical dynamic where producers offload goods deemed too dangerous for domestic use in their home jurisdictions to smaller markets like Barbados, treating local consumers as disposable.
Beyond unsafe imported products, the bill also targets rampant unsubstantiated health advertising that has exploited Barbadians seeking affordable care for serious medical conditions. Caddle told the House that unregulated vendors across the capital Bridgetown openly advertise untested products as cures for terminal illnesses like cancer and a wide range of other ailments, preying on people who may delay or forgo conventional medical treatment due to cost, long wait times for appointments, or longstanding cultural trust in home remedies.
Minister Caddle emphasized that this practice, where vendors sell cheap untested goods to desperate consumers under false promises of healing, borders on criminal activity. Current law does not give regulators the power to crack down on these false claims, whether they are posted on storefront signs, broadcast on radio or television, or spread by word of mouth, leaving a critical regulatory gap that endangers public health. The new legislation will require all health benefit claims for medical products to be independently tested and verified before they can be marketed to the public.
In addition to cracking down on fraud, the bill will also align Barbados’ over-the-counter medication rules with global regulatory standards. Caddle noted that many medications available without a prescription in Barbados are restricted to prescription-only access in other high-regulation jurisdictions, for well-documented safety reasons. The new law will also initiate a broader public conversation about safe consumption of medical and health products among Barbadians, Caddle added.
Calling the long unaddressed gap in regulation a critical threat to public welfare, Caddle urged vendors currently engaging in false advertising to voluntarily end the practice before the bill becomes law, appealing to their conscience to stop exploiting vulnerable Barbadian consumers.